BRIEF published on 04/30/2025 at 18:05, 1 year 4 months ago Neovacs fundraising: a 0.25 million euro operation Biotechnology Fundraising Shareholder Dilution Néovacs OCEANE-BSA
BRIEF published on 04/30/2025 at 18:05, 1 year 4 months ago Levée de fonds de Néovacs : une opération de 0,25 million d'euros Biotechnologie Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire
PRESS RELEASE published on 04/30/2025 at 18:00, 1 year 4 months ago Levée de fonds de 0,25 MEUR Néovacs annonce levée fonds 0,25M€ par émission d'OCEANE-BSA pour financer recherche allergies et investir en Biotech/Medtech. Détails communiqués Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 04/17/2025 at 18:35, 1 year 4 months ago Fundraising of 0.25 Million Euros by Neovacs Fundraising Shareholder Dilution Biotech Néovacs OCEANE-BSA
BRIEF published on 04/17/2025 at 18:35, 1 year 4 months ago Levée de Fonds de 0,25 Million d'Euros par Néovacs Biotech Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire
PRESS RELEASE published on 04/17/2025 at 18:30, 1 year 4 months ago Levée de fonds de 0,25 M EUR Néovacs annonce une levée de fonds de 0,25 M€ par l'émission d'OCEANE-BSA destinée au développement de la recherche Kinoïde® sur les allergies et à l'investissement dans des projets prometteurs en BioTech et MedTech Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 04/16/2025 at 08:05, 1 year 4 months ago Neovacs Addresses Rumors About PXT3003 Biopharmaceuticals Market Authorization PXT3003 Tasly Charcot-Marie-Tooth
BRIEF published on 04/16/2025 at 08:05, 1 year 4 months ago Néovacs s'exprime sur les rumeurs concernant le PXT3003 Biopharmaceutique PXT3003 Tasly Charcot-Marie-Tooth Autorisation Marché
PRESS RELEASE published on 04/16/2025 at 08:00, 1 year 4 months ago Néovacs fait le point sur des rumeurs Néovacs fait le point sur les rumeurs concernant l'autorisation de mise sur le marché de PXT3003 en Chine et l'impact potentiel sur ses actifs. Aucune confirmation disponible pour le moment Autorisation De Mise Sur Le Marché Néovacs PXT3003 Impact Potentiel Procédure De Liquidation
BRIEF published on 04/02/2025 at 20:05, 1 year 5 months ago Adjustment of the nominal value of Neovacs shares Shareholders Capital Reduction Dilutive Financing Nominal Value Néovacs
Published on 09/08/2026 at 15:40, 2 hours 51 minutes ago CANEX Increases Equity Financing to C$9 Million
Published on 09/08/2026 at 15:00, 3 hours 31 minutes ago Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Published on 09/08/2026 at 15:00, 3 hours 31 minutes ago Norsemont to Participate at Precious Metals Summit Beaver Creek
Published on 09/08/2026 at 14:30, 4 hours 1 minute ago Unusual Machines to Participate in Upcoming Investor Conferences
Published on 09/08/2026 at 14:30, 4 hours 1 minute ago Boron One Holdings Inc. - Jarandol Basin Exploration Program Update
Published on 09/08/2026 at 18:20, 11 minutes ago Rönesans Named Among the World's Top 50 International Contractors for the 11th Consecutive Year
Published on 09/08/2026 at 18:00, 31 minutes ago ARVERNE GROUP: Total number of shares and voting rights in the share capital as of August 31, 2026
Published on 09/08/2026 at 18:00, 31 minutes ago ARVERNE GROUP: Nombre total de droits de vote et d’actions composant le capital social au 31 août 2026
Published on 09/08/2026 at 17:40, 51 minutes ago LumApps Appoints Sébastien Cano as Chief Executive Officer
Published on 09/08/2026 at 17:45, 46 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 août 2026
Published on 09/08/2026 at 17:45, 46 minutes ago Chiffre d’affaires semestriel consolidé 2026 : 71,8 M€
Published on 09/08/2026 at 11:00, 7 hours 31 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 09/08/2026 at 11:00, 7 hours 31 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
